Showing results (1-10 of 61) with videos related to
Sort By:
Pageof 7
Rare Diseases (Austin, Tex.)|October 21, 2015
Human iPS cell models of Jervell and Lange-Nielsen syndromeMilena Bellin, Boris GreberFEBS Letters|July 9, 2016
Inherited heart disease - what can we expect from the second decade of human iPS cell research?Milena Bellin, Christine L MummeryFrontiers in Physiology|December 7, 2020
Mechanotransduction and Adrenergic Stimulation in Arrhythmogenic Cardiomyopathy: An Overview of <i>in vitro</i> and <i>in vivo</i> ModelsGiorgia Beffagna, Elena Sommariva, Milena BellinBiomolecules|October 28, 2023
Advance in Genomics of Rare Genetic DiseasesElena Sommariva, Milena Bellin, Chiara Di RestaBritish Journal of Pharmacology|September 20, 2016
Integrating cardiomyocytes from human pluripotent stem cells in safety pharmacology: has the time come?Luca Sala, Milena Bellin, Christine L MummeryFrontiers in Cardiovascular Medicine|January 6, 2022
Inflammation in the Pathogenesis of Arrhythmogenic Cardiomyopathy: Secondary Event or Active Driver?Viviana Meraviglia, Mireia Alcalde, Oscar Campuzano, et al.European Journal of Heart Failure|August 8, 2012
Coronary telangiectasia associated with hypertrophic cardiomyopathyAndrea Frustaci, Gerolamo Lanfranchi, Milena Bellin, et al.Stem Cell Reports|December 18, 2020
Engineered models of the human heart: Directions and challengesJeroen M Stein, Christine L Mummery, Milena BellinBiochemical and Biophysical Research Communications|August 7, 2021
Cardiac microtissues from human pluripotent stem cells recapitulate the phenotype of long-QT syndromeElisa Giacomelli, Luca Sala, Dorien Ward-van Oostwaard, et al.International Journal of Molecular Sciences|November 16, 2018
Large-Scale Simulation of the Phenotypical Variability Induced by Loss-of-Function Long QT Mutations in Human Induced Pluripotent Stem Cell CardiomyocytesMichelangelo Paci, Simona Casini, Milena Bellin, et al.Pageof 7